Boiron

Farmaceutisch bedrijf6 producten gevolgd

producten gevolgd

85.055

totaal meldingen

recalls geregistreerd

81,3%

ernstig algeheel

Producten

6 van 6 getoond

Product	Goedgekeurd	Meldingen ↓	Top signaal	Recalls
ferrous sulfate —	1946	48.897	chronische nierziekte	10
senna leaf —	—	22.469	immuundeficiëntie	0
quinine —	2005	8.945	medicijnmisbruik	2
milk thistle —	—	4.170	probleem met productvervanging	0
cupric oxide —	—	572	winderigheid uit de vagina	0
avobenzone 3%, homosalate 13%, octisalate 5%, octocrylene 10%, oxybenzone 6% —	—	2	—	0

Recall-geschiedenis · 12 geregistreerd

Datum	Klasse	Reden	Bedrijf
17 feb 2025	II	Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.	Safecor Health, LLC
26 apr 2023	II	CGMP Deviations: Firm went out of business and could no longer continue stability studies.	Akorn, Inc.
15 mrt 2021	II	CGMP Deviations: Intermittent exposure to temperature excursion during storage.	Cardinal Health Inc.
31 mei 2019	II	cGMP Deviations: Products may have microbial contamination.	Geritrex, LLC
31 mei 2019	II	cGMP Deviations: Products may have microbial contamination.	Geritrex, LLC
7 mei 2018	II	CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.	RIJ Pharmaceutical LLC
10 apr 2018	III	Presence of Foreign Tablets/Capsules	Aidarex Pharmaceuticals LLC
25 mrt 2016	II	Lack of Processing Controls	Reliable Rexall-A Compounding Pharmacy
14 nov 2014	II	Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.	Attix Pharmaceuticals
2 jul 2013	II	Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) may be potentially mislabeled as RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedigree: AD54549_16, EXP: 5/20/2014.	Aidapak Services, LLC
2 jul 2013	II	Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe) may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: W002711, EXP: 6/6/2014; VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: W002825, EXP: 12/31/2013; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60236_1, EXP: 5/22/2014.	Aidapak Services, LLC
28 dec 2012	I	Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness)	Advance Pharmaceutical Inc

Class I = redelijke kans op ernstige schade · Class II = tijdelijk of omkeerbaar · Class III = onwaarschijnlijk schadelijk.

Registratiestatus

Sommige producten van Boiron zijn niet FDA-geregistreerd voor humaan gebruik. Voor ongeregistreerde stoffen (peptiden, SARMs zonder humane registratie) bestaat geen legitieme leverancier voor humaan gebruik. Het ontbreken van een inkooproute is de veiligheidsinformatie.